The abstract is read at the publisher; the summary is JClub's.
In the KPC orthotopic PDAC mouse model, MyoAAV-driven OPA1 overexpression partially attenuates tibialis anterior mass loss in males and shifts fiber composition toward type IIA in females.
- Why it matters: Mitochondrial dynamics and quality control changes occur before visible muscle wasting in cancer cachexia, but it was unclear whether muscle-targeted modulation could preserve mass and function during systemic wasting.
- What they did: Male and female C57BL/6J mice received bilateral intramuscular MyoAAV encoding murine OPA1 cDNA or BNIP3-targeting shRNA two weeks before KPC1245 implantation, then were evaluated at the humane endpoint for muscle weights, torque/fatigability, fiber types, protein fractional synthesis, oxidative measures, and molecular markers.
- The result: Neither approach prevented systemic wasting, yet in males BNIP3 knockdown improved torque and fatigue resistance and preserved type IIB fibers while lowering DRP1, and both sexes showed reduced mixed-protein synthesis with BNIP3 shRNA.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.